The simultaneous patent expiry of Ozempic’s active ingredient in China and India on Friday is a watershed moment. Until now, the revolutionary weight-loss drugs have been available largely to people ...

Daniel Mays has admitted he was "absolutely terrified" when he read the script of his new ITV drama Believe Me. The actor plays convicted offender John Worboys - who was dubbed the ‘black cab rapist’ ...

A newly-formed Canadian pharmaceutical company is vying to break into the market with a generic version of one of the most well-known prescription drugs in the world: Ozempic. “You could say we’re ...

Q. My doctor diagnosed depression and prescribed me the antidepressant sertraline. Over time, it caused a lack of emotion and a loss of libido. She switched me to Wellbutrin. I experienced no side ...

Sony's latest State of Play showcase on Thursday included a bevy of new trailers, reveals, and more. It was a long one, clocking in at an hour in length, and was chock-full of updates on upcoming ...

The following is a news release from the Idaho Attorney General's Office: BOISE, Idaho — On February 2, 2026, Attorney General Labrador joined a coalition of 48 states and territories announcing ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...

MAIN CHANNEL: Amber Midthunder had a breakout role in the Predator prequel PREY. She discusses with Kristian Harloff about her audition and getting the film and how she hadn't read the script before ...

Many have had the experience of picking up a book they can’t put down, but Sean Penn seemingly had an experience that tops most. Apparently, when Penn first picked up the script for Paul Thomas ...

Performances in N.Y.C. The actor also stars in the Off Broadway production of “This World of Tomorrow,” a yearslong project at the Shed through Dec. 21. The actor also stars in the Off Broadway ...

"Drug development has become slower and more expensive despite all the new technology. That's caused by increased regulatory scrutiny, more needs for quality, more needs for real treatment effects.